|
|
|
Volumn 273, Issue 7318, 2004, Pages 416-
|
|
Why the current situation doubly disadvantages children with cancer
a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
CYTOTOXIC AGENT;
DAUNORUBICIN;
GENERIC DRUG;
MERCAPTOPURINE;
ACUTE LYMPHOCYTIC LEUKEMIA;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CHILD;
CHILD HEALTH CARE;
CHILDHOOD CANCER;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG CONTAMINATION;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG WITHDRAWAL;
EUROPEAN UNION;
HUMAN;
LICENSING;
NOTE;
PHARMACEUTICAL CARE;
PUBLIC HEALTH SERVICE;
QUALITY OF LIFE;
TREATMENT OUTCOME;
UNITED KINGDOM;
|
|
EID: 5044230711
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|